FR2642329B1 - Utilisation de solutions d'atelocollagene et de glycosaminoglycannes pour la fabrication de microcapsules, microcapsules ainsi realisees, procedes de fabrication de telles microcapsules et compositions cosmetiques ou pharmaceutiques ou alimentaires en contenant - Google Patents

Utilisation de solutions d'atelocollagene et de glycosaminoglycannes pour la fabrication de microcapsules, microcapsules ainsi realisees, procedes de fabrication de telles microcapsules et compositions cosmetiques ou pharmaceutiques ou alimentaires en contenant

Info

Publication number
FR2642329B1
FR2642329B1 FR8901221A FR8901221A FR2642329B1 FR 2642329 B1 FR2642329 B1 FR 2642329B1 FR 8901221 A FR8901221 A FR 8901221A FR 8901221 A FR8901221 A FR 8901221A FR 2642329 B1 FR2642329 B1 FR 2642329B1
Authority
FR
France
Prior art keywords
microcapsules
atelocollagen
glycosaminoglycan
cosmetic
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8901221A
Other languages
English (en)
Other versions
FR2642329A1 (fr
Inventor
Marie-Christine Levy
Marie-Christine Andry
Alain Huc
Chantal Buffevant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
Bioetica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioetica SA filed Critical Bioetica SA
Priority to FR8901221A priority Critical patent/FR2642329B1/fr
Priority to EP90400030A priority patent/EP0381543B1/fr
Priority to DE90400030T priority patent/DE69001683T2/de
Priority to AT90400030T priority patent/ATE89766T1/de
Priority to ES90400030T priority patent/ES2058827T3/es
Priority to DK90400030.4T priority patent/DK0381543T3/da
Priority to AU48864/90A priority patent/AU633866B2/en
Priority to KR1019900001111A priority patent/KR0163171B1/ko
Priority to JP2021927A priority patent/JP2534921B2/ja
Priority to CA002009065A priority patent/CA2009065C/fr
Publication of FR2642329A1 publication Critical patent/FR2642329A1/fr
Application granted granted Critical
Publication of FR2642329B1 publication Critical patent/FR2642329B1/fr
Priority to US08/074,701 priority patent/US5395620A/en
Priority to US08/328,903 priority patent/US5622656A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/10—Complex coacervation, i.e. interaction of oppositely charged particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
FR8901221A 1989-01-31 1989-01-31 Utilisation de solutions d'atelocollagene et de glycosaminoglycannes pour la fabrication de microcapsules, microcapsules ainsi realisees, procedes de fabrication de telles microcapsules et compositions cosmetiques ou pharmaceutiques ou alimentaires en contenant Expired - Lifetime FR2642329B1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR8901221A FR2642329B1 (fr) 1989-01-31 1989-01-31 Utilisation de solutions d'atelocollagene et de glycosaminoglycannes pour la fabrication de microcapsules, microcapsules ainsi realisees, procedes de fabrication de telles microcapsules et compositions cosmetiques ou pharmaceutiques ou alimentaires en contenant
DE90400030T DE69001683T2 (de) 1989-01-31 1990-01-05 Verwendung von Atelokollagen und Polyholosiden, z.B. Glykosaminoglykan enthaltende Lösungen zur Herstellung von Mikrokapseln die danach erhaltenen Mikrokapseln und Verfahren zu deren Herstellung; Präparate, welche Nahrungsstoffe, Medikamente oder kosmetische Zusammensetzungen enthalten.
AT90400030T ATE89766T1 (de) 1989-01-31 1990-01-05 Verwendung von atelokollagen und polyholosiden, z.b. glykosaminoglykan enthaltende loesungen zur herstellung von mikrokapseln die danach erhaltenen mikrokapseln und verfahren zu deren herstellung; praeparate, welche nahrungsstoffe, medikamente oder kosmetische zusammensetzungen enthalten.
ES90400030T ES2058827T3 (es) 1989-01-31 1990-01-05 Uso de soluciones de atelocolageno y poliholosidos, por ejemplo glicosaminoglicanos, para la fabricacion de microcapsulas, a microcapsulas preparadas de esta manera, a procedimientos para la fabricacion de estas microcapsulas y a composiciones cosmeticas, farmaceuticas o alimenti
DK90400030.4T DK0381543T3 (da) 1989-01-31 1990-01-05 Anvendelse af opløsninger af atelokollagen og polyholosider, f.eks. glucosaminoglycaner, til fremstilling af mikrokapsler, mikrokapsler fremstillet på denne måde, fremgangsmåder til fremstilling af sådanne mikrokapsler og kosmetiskeeller farmaceutiske sammensætninger eller levnedsmiddelsammensætninger, hvori de er til stede
EP90400030A EP0381543B1 (fr) 1989-01-31 1990-01-05 Utilisation de solutions d'atélocollagène et de glycosaminoglycannes pour la fabrication de microcapsules, microcapsules ainsi réalisées, procédés de fabrication de telles microcapsules et compositions cosmétiques ou pharmaceutiques ou alimentaires en contenant
AU48864/90A AU633866B2 (en) 1989-01-31 1990-01-29 Use of solutions of atelocollagen and polyholosides, for example glycosaminoglycans, for the manufacture of microcapsules,microcapsules produced in this way, processes for the manufacture of such microcapsules and cosmetic, pharmaceutical or food compositions in which they are present
KR1019900001111A KR0163171B1 (ko) 1989-01-31 1990-01-31 마이크로 캡슐의 제조를 위한 글리코스 아미노글리칸과 같은 폴리홀로사이드 및 아텔로 콜라겐의 용액의 용도, 이러한 방법으로 만들어진 마이크로캡슐, 마이크로 캡슐의 제조방법, 및 마이크로 캡슐이 존재하는 화장품, 의약품 또는 식품 조성물
JP2021927A JP2534921B2 (ja) 1989-01-31 1990-01-31 マイクロカプセルおよびその製造方法
CA002009065A CA2009065C (fr) 1989-01-31 1990-01-31 Utilisation de solutions d'atelocollagene et de polyholosides, par exemple des glycosaminoglycanes, pour la fabrication de microcapsules, microcapsules ainsi produites, procedes pour la fabrication de ces microcapsules et compositions cosmetiques, pharmaceutiques ou alimentaires dans lesquelles ces microcapsules sont presentes
US08/074,701 US5395620A (en) 1989-01-31 1993-06-08 Biodegradable microcapsules having walls composed of crosslinked atelocollagen and polyholoside
US08/328,903 US5622656A (en) 1989-01-31 1994-10-25 Process of manufacture of biodegradable microcapsules having walls composed of crosslinked atelocollagen and polyholosides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8901221A FR2642329B1 (fr) 1989-01-31 1989-01-31 Utilisation de solutions d'atelocollagene et de glycosaminoglycannes pour la fabrication de microcapsules, microcapsules ainsi realisees, procedes de fabrication de telles microcapsules et compositions cosmetiques ou pharmaceutiques ou alimentaires en contenant

Publications (2)

Publication Number Publication Date
FR2642329A1 FR2642329A1 (fr) 1990-08-03
FR2642329B1 true FR2642329B1 (fr) 1991-05-24

Family

ID=9378321

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8901221A Expired - Lifetime FR2642329B1 (fr) 1989-01-31 1989-01-31 Utilisation de solutions d'atelocollagene et de glycosaminoglycannes pour la fabrication de microcapsules, microcapsules ainsi realisees, procedes de fabrication de telles microcapsules et compositions cosmetiques ou pharmaceutiques ou alimentaires en contenant

Country Status (1)

Country Link
FR (1) FR2642329B1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665374B1 (fr) * 1990-08-03 1992-12-04 Bioetica Sa Microcapsules a paroi mixte d'atelocollagene et de polyholosides coagulee par un cation bivalent et procede de fabrication de ces microcapsules et des compositions cosmetiques ou pharmaceutiques ou alimentaires en contenant.
FR2680005B1 (fr) * 1991-08-01 1994-09-02 Coletica Utilisation de collagene comme support solide de fixation d'un capteur capable de reagir specifiquement avec un element a detecter dans un milieu biologique, reactif et procede de mise en óoeuvre.
US5648208A (en) * 1991-08-01 1997-07-15 Coletica Use of a collagen as solid binding substrate for a ligand capable of reacting specifically with an element to be detected in a biological medium, reactant and implementation
FR2683159B1 (fr) 1991-10-31 1994-02-25 Coletica Procede de fabrication de nanocapsules a paroi a base de proteines reticulees; nanocapsules ainsi obtenues et compositions cosmetiques, pharmaceutiques et alimentaires en comportant application.
FR2774907B1 (fr) * 1998-02-19 2000-05-12 Luc Dewandre Nouvelle formulation topique a base de retinaldehyde
FR2777193B1 (fr) * 1998-04-14 2001-06-08 Coletica Particule a groupement hydroxamique chelatante d'ions metalliques et leur utilisation en cosmetique ou en pharmacie
US7468195B2 (en) 2000-06-09 2008-12-23 Crawford Healthcare Limited Skin treatment preparation
ES2226567B1 (es) * 2003-06-20 2006-07-01 Universidad De Santiago De Compostela Nanoparticulas de acido hialuronico.
ATE544493T1 (de) 2003-12-04 2012-02-15 Dsm Ip Assets Bv Mikrokapseln mit uv-filter-wirkung udn verfahren zu ihrer herstellung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5814253B2 (ja) * 1974-04-10 1983-03-18 カンザキセイシ カブシキガイシヤ ビシヨウカプセルノ セイゾウホウホウ
FR2608456B1 (fr) * 1986-12-18 1993-06-18 Mero Rousselot Satia Microcapsules a base de gelatine et de polysaccharides et leur procede d'obtention

Also Published As

Publication number Publication date
FR2642329A1 (fr) 1990-08-03

Similar Documents

Publication Publication Date Title
FR2634376B1 (fr) Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
FR2714670B1 (fr) Nouveau ligand polypeptidique, sa préparation, composition pharmaceutique le contenant, et son application à la production de thrombopoïétine.
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
DE69319440T2 (de) Herstellung von pharmazeutischen zusammensetzungen, die calcitonin enthalten
DE3882461T2 (de) Retroreflektierendes Überzugsmittel und Zusammensetzung zu seiner Herstellung.
IT8423086A0 (it) Composizione farmaceutica o dietetica ad elevata attivita'antitrombotica e antiarteriosclerotica.
FR2651131B1 (fr) Nouvelles compositions cosmetiques contenant du chitosane et de la glucosamine.
CA2015952A1 (fr) Antisudorifique
IT8521603A0 (it) Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi.
FR2642329B1 (fr) Utilisation de solutions d'atelocollagene et de glycosaminoglycannes pour la fabrication de microcapsules, microcapsules ainsi realisees, procedes de fabrication de telles microcapsules et compositions cosmetiques ou pharmaceutiques ou alimentaires en contenant
FR2628973B1 (fr) Composition cosmetique ou pharmaceutique a usage cutane, et procede pour la preparation d'une telle composition
IT8324430A0 (it) Attivita' antitosse e sedativa composti otticamente attivi ad centrale, procedimento per la loro preparazione e composizioni che licontengono.
DE69002520D1 (de) Azeotropaehnliche zusammensetzungen von 1,1-dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1-fluoraethan.
FR2705232B1 (fr) Procédé pour la préparation de particules préparées à sec, particules préparées à sec ainsi obtenues et compositions pharmaceutiques contenant de telles particules.
GB9022572D0 (en) Use of glycoprotein extracts of gram(-)bacteria for the manufacture of comestic or dermatological compositions and compositions containing them
FR2654341B1 (fr) Utilisation d'ifenprodil et de ses derives pour la fabrication de medicaments antipsychotiques.
FR2714603B1 (fr) Composition dermatologique et son utilisation pour la préparation d'un médicament.
FR2724318B1 (fr) Composition cosmetique prevenant ou attenuant la photo-reactivite de manopigments de dioxyde de titane
FR2575159B1 (fr) Nouvelles 8a-acylaminoergolines, leur preparation, leur utilisation comme medicaments et les compositions pharmaceutiques les contenant
FR2611497B1 (fr) Agglomerats, leur preparation et compositions pharmaceutiques et/ou cosmetiques les contenant
IT1186754B (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8 fenil-10 antrone-9,e procedimento di preparazione dell'ingrediente attivo
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
IT9047551A0 (it) Impiego di a-amminofluorochetoni per la preparazione di medicamenti ad attivita' cardiovascolare e antipertensiva.
BE888984A (fr) Halogenures d'alkoxy-acyl carnitines, leur preparation et compositions pharmaceutiques en contenant
FR2684299B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.

Legal Events

Date Code Title Description
CD Change of name or company name